点击注册小程序 特别申明： 铸造与精加工产能建设同步推进，有望受益于25年风电建设加速 公司稳定推进各项产能提升工作，截至2024年底，公司已形成年产70万吨铸造产能规模和42万吨精加工产 能；后续随着"年产22万吨大型铸件精加工项目"剩余12万吨精加工产能建设持续推进，投产后公司将形成 54万吨精加工产能规模，逐步构建"一体化交付"产业链以提升加工环节利润。随着25年风电建设需求高 增，公司在具有充足产能的基础上，有望充分受益。 积极拓展核电与合金钢业务，打开业绩成长空间 公司通过球墨铸铁厚大断面技术在核电装备运用和合金钢领域研究贯通，积极布局多领域。核电方面，公 司持续投入资源研发核电乏燃料转运储存罐，已具备批量制造能力。合金钢方面，公司进入高端合金钢市 场，积极拓展研发新能源汽车大型压铸机对铸铁、铸钢需求的产品。24年公司合金钢业务实现营收0.78亿 元，同比增长50.71%，毛利率同比上升1.35pct至4.73%，未来有望推动业绩增长。 风险提示： 风电装机不及预期、原材料价格波动风险、新业务拓展不及预期。 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体 ...

公司研究 24 年业绩符合预期，有望受益于风电建设加速 2025 年 5 月 5 日 要点 事件：公司发布 2024年年报，2024年实现营业收入46.96亿元，同比增长0.87%； 归母净利润 6.24 亿元，同比增长 29.55%；扣非归母净利润 3.33 亿元，同比减 少 21.57%；拟向全体股东每股派发现金红利 0.35 元（含税）。公司同时发布 2025 年一季报，2025Q1 实现营业收入 13.01 亿元，同比增长 86.41%，环比减 少 13.94%；归母净利润 1.21 亿元，同比增长 39.14%，环比增长 2.97%。 24 年需求回暖推动公司出货微增，盈利能力仍有所承压。2024 年国内风电建设 需求有所回暖，使得公司主营产品销量微增，铸件类产品销售同比增长 9.58% 至 49.04 万吨；球墨铸铁类产品实现营业收入 42.66 亿元，同比减少 5.30%， 毛利率同比下降 0.47pct 至 17.84%。在风机价格持续处于低位的背景下，风电 产业链盈利空间持续受到挤压，24 年公司销售毛利率同比下降 1.32pct 至 17.34%，25Q1 同比下降 6.24pct 至 1 ...

Core Insights - The company reported a mixed performance in revenue, profit, and cash flow for 2024, with significant changes in various financial metrics [1] Revenue - The company achieved a revenue of 4,695,947,539.30 CNY, a slight increase of 0.87% from the previous year [2] - The core revenue source is the casting business, contributing 462,075.48 million CNY, with a notable decline in ductile iron product revenue by 5.30% [2] - Domestic sales decreased by 0.98% to 388,394.93 million CNY, while international sales increased by 5.86% to 73,680.55 million CNY [2] Profit - Net profit attributable to shareholders rose by 29.55% to 623,809,070.27 CNY, largely due to non-recurring gains from the disposal of subsidiary equity [3] - Excluding non-recurring items, the net profit fell by 21.57% to 333,258,314.06 CNY, indicating underlying profit pressure from declining sales prices [3] Earnings Per Share - Basic earnings per share increased by 29.79% to 0.61 CNY, while the adjusted earnings per share decreased by 19.51% to 0.33 CNY, reflecting reliance on non-recurring gains [4] Expenses - Sales expenses significantly decreased by 59.18% to 16,255,033.77 CNY, attributed to a change in cost allocation [5] - Management expenses grew by 6.82% to 188,298,893.08 CNY, driven by increased asset depreciation and amortization [6] - Financial expenses decreased by 44.47% to -57,596,479.28 CNY, influenced by reduced foreign exchange gains and interest income [7] - R&D expenses fell by 12.09% to 227,436,636.07 CNY, raising concerns about future innovation capabilities [8] Cash Flow - Operating cash flow net amount decreased by 125.67% to -158,231,624.33 CNY, indicating potential liquidity issues [11] - Investment cash flow net amount increased significantly to 824,217,577.85 CNY, reflecting improved capital recovery [12] - Financing cash flow net amount decreased by 18.69% to 357,688,613.48 CNY, suggesting a cautious approach to funding [13] R&D and Personnel - The company maintains a stable R&D personnel structure with 308 employees, focusing on continuous technological innovation despite reduced R&D spending [10] Risks - The company faces risks related to raw material price fluctuations, market demand volatility, and potential operational challenges due to its significant fixed asset investments [14]